Golden Ally Lifetech Group, Inc.
AQPW
$0.2694
$0.049322.40%
03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 23.66% | 1,647.40% | -- | 15,088.46% | -- |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 23.74% | 1,786.28% | 1,493.82% | 15,143.27% | 4,230.68% |
Operating Income | -23.74% | -1,786.28% | -1,493.82% | -15,143.27% | -4,230.68% |
Income Before Tax | -23.74% | -1,786.28% | -- | -15,153.85% | -- |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -23.74% | -1,786.28% | -- | -15,153.85% | -- |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -23.74% | -1,786.28% | -1,493.82% | -15,153.85% | -4,230.68% |
EBIT | -23.74% | -1,786.28% | -1,493.82% | -15,143.27% | -4,230.68% |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -50.00% | -- | 95.35% | 60.00% | 91.30% |
Normalized Basic EPS | -100.00% | -- | -- | 66.67% | -- |
EPS Diluted | -50.00% | -- | 95.35% | 60.00% | 91.30% |
Normalized Diluted EPS | -100.00% | -- | -- | 66.67% | -- |
Average Basic Shares Outstanding | -12.82% | -54.08% | 41,171.55% | 38,448.05% | 91,084.90% |
Average Diluted Shares Outstanding | -12.82% | -54.08% | 41,171.55% | 38,448.05% | 91,084.90% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |